Frontlight ResearchEarly access
CompletedPhase 2
Ketamine in Patients Undergoing TEVAR Procedures Receiving NCI
Key facts
- Who runs it
- Eric Johnson
- Where
- Lexington, United StatesSee the site
- Trial code
- Status
- Completed
- Phase
- Phase 2
- People taking part
- 21 people enrolled
- Started
- 8 Dec 2020
- Ended
- 17 Oct 2025
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Saline
- Ketamine
- Record updated
- 21 September 2026
Who can take part
- Age
- 18 years to 90 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (8)Hide the full registry criteria
Who can take part
- willing to give informed consent
- scheduled for elective thoracic aorta repair or thoracoabdominal aortic repair
- requires naloxone continuous infusion for spinal prophylaxis
Who cannot take part
- allergy to ketamine, acetaminophen, or fentanyl
- history of hydrocephalus or central nervous system mass
- diagnosis of schizophrenia
- incarcerated individuals
- pregnant or lactating individuals
Where in United States
- University of Kentucky Medical CenterLexington, United States
About the trial
What the trial wants to find out
The objective of this study is to identify the opioid-sparing effects, and pain-reduction potential of low dose, sub-dissociative ketamine on patients undergoing thoracic endovascular aortic repair (TEVAR) procedures receiving naloxone continuous infusion (NCI).
The 2 groups in the trial
- Standard of CarePlacebo, for comparison
Participants in this group will receive standard of care as well as a saline infusion during the study period.
Treatment: Saline
- Sub-Dissociative KetamineTreatment being tested
Participants in this group will receive standard of care as well as a continuous ketamine infusion at the induction of anesthesia and for 48 hours postoperatively.
Treatment: Ketamine
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Randomized, Double-blind, Placebo-controlled, Study to Identify the Opioid-sparing Effects, and Pain-reduction Potential of Low Dose Ketamine on Patients Undergoing TEVAR Procedures Receiving NCI
- Record updated
- 21 September 2026